26241343|t|Allopregnanolone increases mature excitatory synapses along dendrites via protein kinase A signaling.
26241343|a|Allopregnanolone (APalpha; 5alpha-pregnan-3alpha-ol-20-one) is synthesized in both the periphery and central nervous system and is known to be a potent positive allosteric modulator of the GABAA receptor. Because APalpha was suggested to improve the symptoms of depression and Alzheimer's disease (AD), which involve synaptic dysfunction and loss, we examined whether APalpha affects excitatory synapses. Drebrin, which is an actin-binding protein, forms a unique stable actin structure in dendritic spines, and drebrin levels correlate positively with cognitive levels in AD and mild cognitive impairment. We investigated whether APalpha increases excitatory synapse density along dendrites of mature hippocampal neurons using drebrin-imaging-based evaluation of mature synapses. We prepared primary cultures of hippocampal neurons and either transfected them with GFP or immunostained them against drebrin. Morphological analysis of GFP-transfected neurons revealed that a 24-h exposure to 0.3 or 1 muM APalpha significantly increased dendritic spine density without any morphological changes to spines. Drebrin cluster density was also increased by 0.3 and 1 muM APalpha. The protein kinase A (PKA) inhibitor H-89 inhibited the APalpha-induced increase in drebrin cluster density. These data demonstrate that APalpha increases mature excitatory synapses via activation of PKA. Therefore, the PKA-cAMP response element-binding protein (CREB) signaling pathway is likely to be involved in the APalpha-induced increase of mature excitatory synapses. Another possibility is that the PKA-dependent increase in AMPA receptors at dendritic spines mediates the APalpha function. In conclusion, our study indicates that APalpha may improve neuropsychiatric disorder outcomes via increasing the numbers of mature excitatory synapses.
26241343	0	16	Allopregnanolone	Chemical	MESH:D011280
26241343	102	118	Allopregnanolone	Chemical	MESH:D011280
26241343	120	127	APalpha	Gene	2028
26241343	129	160	5alpha-pregnan-3alpha-ol-20-one	Chemical	-
26241343	315	322	APalpha	Gene	2028
26241343	364	374	depression	Disease	MESH:D003866
26241343	379	398	Alzheimer's disease	Disease	MESH:D000544
26241343	400	402	AD	Disease	MESH:D000544
26241343	428	439	dysfunction	Disease	MESH:D006331
26241343	470	477	APalpha	Gene	2028
26241343	507	514	Drebrin	Gene	1627
26241343	614	621	drebrin	Gene	1627
26241343	675	677	AD	Disease	MESH:D000544
26241343	687	707	cognitive impairment	Disease	MESH:D003072
26241343	733	740	APalpha	Gene	2028
26241343	830	837	drebrin	Gene	1627
26241343	1002	1009	drebrin	Gene	1627
26241343	1107	1114	APalpha	Gene	2028
26241343	1208	1215	Drebrin	Gene	1627
26241343	1268	1275	APalpha	Gene	2028
26241343	1314	1318	H-89	Chemical	MESH:C063509
26241343	1333	1340	APalpha	Gene	2028
26241343	1361	1368	drebrin	Gene	1627
26241343	1414	1421	APalpha	Gene	2028
26241343	1540	1544	CREB	Gene	1385
26241343	1596	1603	APalpha	Gene	2028
26241343	1758	1765	APalpha	Gene	2028
26241343	1816	1823	APalpha	Gene	2028
26241343	1836	1861	neuropsychiatric disorder	Disease	MESH:D001523
26241343	Negative_Correlation	MESH:D000544	2028
26241343	Negative_Correlation	MESH:C063509	1627
26241343	Positive_Correlation	1627	2028
26241343	Negative_Correlation	MESH:C063509	2028
26241343	Negative_Correlation	MESH:D003866	2028
26241343	Association	MESH:D000544	1627
26241343	Association	1385	2028
26241343	Association	MESH:D006331	2028
26241343	Association	MESH:D003072	1627
26241343	Negative_Correlation	MESH:D001523	2028

